FDA Inspection 1085580 — The University Of Texas MD Anderson Cancer Center IRB

The University Of Texas MD Anderson Cancer Center IRB — FEI 1626261

The FDA completed an inspection of The University Of Texas MD Anderson Cancer Center IRB on Mar 12, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.